192329-91-2Relevant articles and documents
The involvement of the mitochondrial amidoxime reducing component (MARC) in the reductive metabolism of hydroxamic acidsS
Ginsel, Carsten,Plitzko, Birte,Froriep, Danilo,Stolfa, Diana A.,Jung, Manfred,Kubitza, Christian,Scheidig, Axel J.,Havemeyer, Antje,Clement, Bernd
supporting information, p. 1396 - 1402 (2018/09/13)
The mitochondrial amidoxime reducing component is a recently discovered molybdenum enzyme in mammals which, in concert with the electron transport proteins cytochrome b5 and NADH cytochrome b5 reductase, catalyzes the reduction of N-oxygenated structures.
Radiolabelled MMP selective compounds
-
Page/Page column 11, (2009/12/05)
The invention is directed to radiolabelled MMP selective compounds, a processes for the preparation thereof, and uses thereof. The derivatives of the invention have formula (I) wherein Y represents O, CH2, (CH2)2, S, NH, o
3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
-
, (2008/06/13)
A compound of the formula wherein R1, R2and Q is as defined above, are useful in the treatment of a arthritis (including osteoarthritis and rheumatoid arthritis), cancer (such as solid tumor cancer including colon cancer, breast canc